QIR Suite vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CASIS Cardiac Simulation & Imaging Software
VS
by Volta Medical

AI Verdict

Tool A, QIR Suite, specializes in the diagnostic and prognostic analysis of cardiovascular conditions through quantitative evaluation of MR and CT images. In contrast, Tool B, VX1+, is designed to assist electrophysiologists in real-time during cardiac ablation procedures by identifying abnormal electrograms. While both are FDA-cleared cardiology AI tools, they serve different phases of patient care and utilize distinct data modalities.

Choose QIR Suite if…

Choose QIR Suite if you require comprehensive, AI-powered quantitative analysis of cardiac MR and CT images for diagnostic and prognostic purposes. This tool is ideal for detailed pre-procedural planning, assessing cardiovascular conditions, and monitoring disease progression through precise quantification of over 100 clinical parameters.

View QIR Suite →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist seeking real-time AI assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to identify abnormal electrograms and provide actionable insights directly within the operating room, enhancing decision-making during the intervention.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature QIR Suite VX1+
Pricing Contact for pricing Unknown
Deployment Locally on dedicated hardware Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1+

VX1+ emphasizes a 'simple user interface with color coding' and is described as 'intuitive, user-friendly' for real-time procedures, aiming to reduce inter-operator variability without lengthening procedure time. QIR Suite also claims optimized ergonomics and a user-friendly interface, but VX1+'s focus on immediate, unambiguous usability in a high-stakes interventional setting gives it a slight edge.

Clinical Value

VX1+

While QIR Suite offers comprehensive quantitative analysis for diagnosis and prognosis across various cardiovascular conditions with claims of increased accuracy, VX1+ has demonstrated superior clinical outcomes in a randomized controlled trial (TAILORED-AF) for persistent AFib ablation. The trial showed 88% of patients with AI-targeted ablations were free of AFib symptoms within one year, compared to 70% with standard treatment, providing strong evidence of direct patient benefit.

Pricing & Value

QIR Suite

Neither tool provides publicly available pricing details. However, QIR Suite at least specifies its pricing models, offering a 'One-time license fee; Subscription,' which provides some insight into potential cost structures. VX1+ offers no public information on pricing or its pricing models.

Enterprise Readiness

VX1+

VX1+ explicitly highlights its seamless integration with 'existing EP recording and 3D mapping systems' and compatibility with 'existing 510(k)-cleared catheters and specific data acquisition systems,' demonstrating a strong focus on fitting into current hospital workflows. QIR Suite also supports PACS/HL7 integration and is vendor-neutral, but VX1+'s detailed compatibility and real-time procedural integration make it particularly robust for enterprise adoption in its specialized field.

Innovation

VX1+

Both tools leverage AI for complex cardiovascular tasks. QIR Suite offers advanced quantitative imaging analysis, including a 'world first solution to automatically evaluate a myocardial infarction.' However, VX1+'s real-time, AI-guided assistance during live cardiac ablation procedures, being the 'first FDA clearance for an AI based tool in interventional cardiac electrophysiology,' represents a higher degree of novelty and immediate decision-support in a dynamic surgical environment.

Support & Docs

Tie

The provided structured facts and web searches do not offer sufficient specific details regarding the quality, availability, or scope of customer support, training programs, or documentation for either QIR Suite or VX1+. While both companies allude to some form of support or documentation, there is not enough information to differentiate them meaningfully.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature QIR Suite VX1+
Primary Use Case AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Company CASIS Cardiac Simulation & Imaging Software Volta Medical
Target Specialties Cardiology, Radiology Cardiology
Key AI Functionality AI-based analysis of MR and CT examinations, Detection of heart regions and pathological areas, Quantification of over 100 clinical parameters, Automatic segmentation, Blood flow/velocities quantification, Pathological volumes detection and quantification, Semi-quantification of myocardial perfusion, Strain quantification Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart, Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, AI-driven insights to assist electrophysiologists during ablation procedures, Booster mode for increased sensitivity during AT or slow AF, Provides cycle length estimation from electrograms
Data Input/Analysis Type MR and CT images Electrograms (EP data), 3D anatomical and electrical maps

Videos

Demos, reviews, and walkthroughs featuring QIR Suite and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

QIR Suite is an AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis, primarily for cardiologists and radiologists. VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
QIR Suite is deployed locally on dedicated hardware. VX1+ is a software application that integrates with existing EP recording and 3D mapping systems, such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
QIR Suite analyzes MR and CT images. VX1+ analyzes electrogram data from EP recording and 3D mapping systems.
QIR Suite offers AI-based analysis including detection of heart regions, pathological areas, quantification of over 100 clinical parameters, automatic segmentation, blood flow/velocities, pathological volumes, semi-quantification of myocardial perfusion, and strain quantification. VX1+ provides real-time manual or automatic annotation of 3D anatomical and electrical maps, identification of spatio-temporal dispersed electrograms (DEs), AI-driven insights during ablation, and cycle length estimation from electrograms.
AI Tool Finder
AI-powered search. Results may not be comprehensive.